Prometheus Biosciences, Inc.

Prometheus Biosciences, Inc.

Biotechnology Research

San Diego, California 8,061 followers

Revolutionizing medicine with precision.

About us

We’re a different kind of biotech company. And we’re here to make a difference. Prometheus Biosciences, Inc. (Nasdaq: RXDX), is a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery, development and commercialization of novel therapeutic and companion diagnostic products for the treatment of immune-mediated diseases. The Company’s precision medicine platform, Prometheus360™, combines proprietary machine learning-based analytical approaches with one of the world’s largest gastrointestinal bioinformatics databases to identify novel therapeutic targets and develop therapeutic candidates to engage those targets. Prometheus Biosciences was named Best Places to Work by Biospace in 2022 and is headquartered in San Diego, CA.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
San Diego, California
Type
Public Company
Founded
1995
Specialties
Bioinformatics, Data Science, diagnostics, therapeutics, and precision medicine

Locations

Employees at Prometheus Biosciences, Inc.

Affiliated pages

Similar pages

Browse jobs

Funding

Prometheus Biosciences, Inc. 6 total rounds

Last Round

Post IPO equity

US$ 500.0M

See more info on crunchbase